Over 20 Cleansweep Auctions End Tomorrow 06/25 - Bid Now

GE HealthCare to feature mobile mammography screening truck along with latest AI platform at SBI2024 Breast Cancer Imaging Showc

Press releases may be edited for formatting or style | April 12, 2024 Mobile Imaging Women's Health

With Pristina Bright, clinicians can see lesions that cannot be seen on routine mammography[4] [5] [6] and biopsy what is seen within 15 minutes.[7] To help improve overall productivity, Pristina Bright can also help providers take more patients on their system, with the ability to image up to 30 patients a day with contrast mammography[8] through an easy-to-read exam.

“Through our research and clinical experiences, contrast enhanced mammography (CEM) continues to emerge as game-changer in helping to improve breast cancer outcomes for patients facing this difficult diagnosis,” shares Dr. Jordana Phillips – Radiologist at Boston Medical Center. “When it comes to findings that are difficult to define, CEM leverages the addition of a contrast agent to highlight unusual areas of blood flow - providing an efficient yet familiar, patient-centric approach to evaluate the presence of cancer with high sensitivity and specificity. With contrast, we’re able to turn a normal mammogram into something that provides so much more information which accelerates our ability to make a confident diagnosis. We’re excited to be joining GE HealthCare and the breast imaging community at SBI 2024 to share more about our experience through the hands-on learning course, as well as share how we’ve implemented CEM as part of our efforts to provide personalized breast cancer care to community we serve.”

As part of the company’s commitment to enabling access to healthcare, GE HealthCare will have its mobile mammography showcase onsite. Attendees will have the unique opportunity to explore the capabilities of this unit designed to offer convenient screening set-up within the familiar environment of a workplace. The truck is equipped with the Senographe Pristina and Invenia ABUS to ensure accurate and efficient screenings.

Back to HCB News

You Must Be Logged In To Post A Comment